|
March
13, 2008
Rainwaters
Restaurant
1202 Kettner Blvd.
San Diego, CA 92101
619-233-5757
WHO
ATTENDED
6:30
pm: Network Reception
7:30
pm: Dinner & Speaker
| Speaker: |
Dr.
Craig V. Comiter, M.D.,
Stanford University Medical Center |
| |
|
| Topics: |
"New
Understanding of the Pathophysiology of Overactive Bladder"
& |
| |
"Nuts
and Bolts of Post Prostatectomy Incontinence" |
| At
the conclusion of these activities, the participant will
be able to: |
| 1) |
Understand the pathophysiology of overactive bladder. |
| 2) |
Offer
options for patients who fail pharmacotherapy. |
| 3) |
Understand
the evaluation and management of post-prostatectomy incontinence. |
| 4) |
Understand
when to offer sling versus artificial sphincter. |
 |
Education
MD: 1992, Harvard Medical School, Boston, MA
Residencies: 1992-1994, Brigham & Woman's Hospital,
Boston, MA
1994-1998, Harvard Program in Urology, Boston, MA
Fellowship 1998-1999, Neurourology and Female Urology,
University of California-Los Angeles, Los Angeles, CA
Clinical Specialties
Urology, Female Urology and Urodynamics |
|
Board
Certifications
American Board of Urology
Research
I am involved in several clinical studies. I currently
am evaluating two novel and minimally invasive surgical
techniques for urinary incontinence: an incisionless
sling for female stress incontinence, and a male sling
for post-prostatectomy incontinence. In addition, I
am conducting a clinical trial of sacral neuromodulation
for the treatment of interstitial cystitis and how it
affects the urinary symptoms, as well as the chronic
pelvic pain associated with the illness.
I
also am involved in a multi-center study of a new implantable
nerves stimulator for the treatment of urinary urgency
and urinary urgency incontinence. In addition, I am
involved in a novel treatment for pelvic pain and interstitial
cystitis, using an implantable neural stimulator. I
am part of a multi-center study of a new injectable
substance for the non-operative treatment of female
stress incontinence, and in a multi-center study of
a new once-daily oral medication for overactive bladder.
Additionally, in collaboration with my urodynamic nursing
staff, we are evaluating the utility of new and useful
urodynamic techniques for the evaluation of voiding
dysfunction. At the VA Medical Center, I am an investigator
for the study of the affect of selenium on prostate
cancer progression and prevention. Finally, I am principal
investigator for a new type of sling procedure for urinary
incontinence following prostate cancer surgery.
Currently,
I save several exciting basic science research projects,
including a novel treatment for interstitial cystitis,
and 3 new treatments for bening prostatic enlargement
and overactive bladder.
Recently,
I served as principal investigator for a NIH-funded
study regarding the treatment of chronic prostatitis.
I was also the lead investigator for a new type of sling
material for female bladder neck suspension surgery.
I was also the principal investigator for a research
study involving a new type of muscarinic receptor blocker
for the treatment of overactive bladder and urinary
incontinence.
|
|
Meeting
Fees
|
No
charge to:
Members who have paid their 2007 & 2008 Dues.
Resident Members |
$25
Fee to:
Senior Members
Health Professionals |
SDUS
Non-Members:
click for
Membership Information |
|
|
